Stroma Biosciences
Biotechnology
Targeting the stroma microenvironment to sensitise cancers to chemotherapeutics ‘Spatial Synthetic Lethality’
About us
Discovering novel stroma-instrinic targets and therapeutics specifically targeting these mechanisms in a broad range of diseases
- Website
-
http://stroma.bio
External link for Stroma Biosciences
- Industry
- Biotechnology
- Company size
- 2-10 employees
- Headquarters
- Cambridge
- Type
- Privately Held
- Founded
- 2020
Locations
-
Primary
Get directions
Cambridge, GB
Employees at Stroma Biosciences
-
John Beadle
Chairman and Non-Executive Director
-
Andrew Moore
Co-Founder and CTO at Stroma Biosciences Limited
-
Michael Salako PhD MBA
Venture Capital Investor | Life Sciences & Healthcare
-
Ingo Ringshausen
Principal Investigator at the UNIVERSITY COLLEGE LONDON & Consultant Haematologist UCLH